Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Type
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. Application outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Bioelectric Medicine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Bioelectric Medicine Market Analysis Tools
3.4.1. Industry Analysis – Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technological landscape
3.4.2.5. Environment landscape
3.4.2.6. Legal Landscape
Chapter 4. Bioelectric Medicine Market: Product Estimates & Trend Analysis
4.1. Bioelectric Medicine Market: Key Takeaways
4.2. Bioelectric Medicine Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Implantable Cardioverter Defibrillators
4.3.1. Implantable cardioverter defibrillators market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Cardiac Pacemakers
4.4.1. Cardiac pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Cochlear Implants
4.5.1. Cochlear implants market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Spinal Cord Stimulators
4.6.1. Spinal cord stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Deep Brain Stimulators
4.7.1. Deep brain stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Transcutaneous Electrical Nerve Stimulators
4.8.1. Transcutaneous electrical nerve stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Sacral Nerve Stimulators
4.9.1. Sacral nerve stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Vagus Nerve Stimulators
4.10.1. Vagus nerve stimulators market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Others
4.11.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Bioelectric Medicine Market: Type Estimates & Trend Analysis
5.1. Bioelectric Medicine Market: Key Takeaways
5.2. Bioelectric Medicine Market: Type Movement & Market Share Analysis, 2022 & 2030
5.3. Implantable Electroceutical Devices
5.3.1. Implantable electroceutical devices market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Non-Invasive Electroceutical Devices
5.4.1. Non-invasive electroceutical devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Bioelectric Medicine Market: Application Estimates & Trend Analysis
6.1. Bioelectric Medicine Market: Key Takeaways
6.2. Bioelectric Medicine Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Arrhythmia
6.3.1. Arrhythmia market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Pain Management
6.4.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Sensorineural Hearing Loss
6.5.1. Sensorineural hearing loss market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Parkinson’s Disease
6.6.1. Parkinson’s disease market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Tremor
6.7.1. Tremor market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Depression
6.8.1. Depression market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. Treatment-resistant Depression
6.9.1. Treatment-resistant depression market estimates and forecasts, 2018 to 2030 (USD Million)
6.10. Epilepsy
6.10.1. Epilepsy market estimates and forecasts, 2018 to 2030 (USD Million)
6.11. Urinary and Fecal Incontinence
6.11.1. Urinary and fecal incontinence market estimates and forecasts, 2018 to 2030 (USD Million)
6.12. Others
6.12.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Bioelectric Medicine Market: End-use Estimates & Trend Analysis
7.1. Bioelectric Medicine Market: Key Takeaways
7.2. Bioelectric Medicine Market: End-use Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Others
7.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Bioelectric Medicine Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Bioelectric Medicine Market by Region: Key Marketplace Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.5. South Korea
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. Medtronic
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Abbott
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Boston Scientific Corporation
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Cochlear Ltd.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. LivaNova PLC
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Biotronik SE & Co. KG
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. electroCore, Inc.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Sonova
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Nevro Corp.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Stimwave LLC
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/